Product Information
ONDANSETRON HCL 4 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0582 per EA under NDC 57237007530. Its NADAC has been published 539 times since Jun 8, 2016.
FDA first approved this application on Jul 31, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237007530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ONDANSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078539FDA Approved
7/31/2007
TE Code
AB
On Market Since
7/31/2007
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON HCL 4 MG TABLET has been published 539 times since Jun 8, 2016, and over the history we have for it it has declined 55.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0582 per EA |
|---|---|
| All-time high | $0.1555 (Apr 12, 2017) |
| All-time low | $0.0555 (Jul 17, 2024) |
| 52-week high | $0.0691 |
| 52-week low | $0.0582 |
| Median price | $0.0757 |
| Average price | $0.0830 |
| Largest weekly change | +27.2% (Aug 21, 2024) |
| Weeks tracked | 539 |
| Tracking since | Jun 8, 2016 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ondansetron Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON HCL 4 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0582 per EA (NDC 57237007530), effective Sep 30, 2026.
How has the price of ONDANSETRON HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONDANSETRON HCL 4 MG TABLET has declined 55.7%. It has been tracked across 539 weekly CMS publications since Jun 8, 2016.
What are the highest and lowest recorded NADAC prices for ONDANSETRON HCL 4 MG TABLET?
Since Jun 8, 2016, the NADAC for ONDANSETRON HCL 4 MG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.1555 (Apr 12, 2017), with a median of $0.0757 per EA.
Are there cheaper alternatives to ONDANSETRON HCL 4 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ONDANSETRON HCL 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ONDANSETRON HCL 4 MG TABLET?
ONDANSETRON HCL 4 MG TABLET (NDC 57237007530) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.